Wednesday, December 21, 2022

WHO chief ‘very concerned’ over COVID situation in China

WHO head Tedros Adhanom Ghebreyesus appeals for detailed information as China battles a surge of COVID cases.

Published On 21 Dec 2022



China could be struggling to keep a tally of COVID-19 infections as the country experiences a big spike in cases, a senior World Health Organization official has said, amid concerns about a lack of data from the country.

Official figures from China have become an unreliable guide as less testing is being done across the country following the recent easing of the strict “zero-COVID” policy.

“In China, what’s been reported is relatively low numbers of cases in ICUs, but anecdotally ICUs are filling up,” WHO’s emergencies director Mike Ryan said on Wednesday.

“I wouldn’t like to say that China is actively not telling us what’s going on. I think they’re behind the curve.”

WHO head Tedros Adhanom Ghebreyesus also said he was “very concerned” about the situation in China.

“WHO is very concerned over the evolving situation in China,” Tedros told a weekly news conference, appealing for detailed information on disease severity, hospital admissions and intensive care requirements.

Vaccines from Germany


The WHO said it was ready to work with China to improve the way the country collects data around critical factors such as hospitalisation and death.

China uses a narrow definition of COVID deaths and reported no new fatalities for Tuesday, even crossing one off of its overall tally since the pandemic began, now at 5,241 – a fraction of the tolls of many much less populous countries.

The National Health Commission said only deaths caused by pneumonia and respiratory failure in patients who had the virus are classified as COVID deaths.

Ryan noted that there had been a surge in vaccination rates in the country over the last weeks, adding that it remains to be seen whether enough vaccination can be done in the coming weeks to stave off the effect of an Omicron wave

.
Beds are seen in a fever clinic that was set up in a sports area as coronavirus disease outbreaks continue in Beijing [Thomas Peter/Reuters]

The WHO would encourage work to import vaccines, but also to find arrangements where vaccines can be produced in as many places as possible, Ryan said.

China has nine domestically developed COVID-19 vaccines approved for use, more than any other country, but they have not been updated to target the highly infectious Omicron variant.

Germany has sent its first batch of BioNTech COVID-19 vaccines to China to be administered initially to German expatriates, government spokesman Steffen Hebestreit said, the first foreign coronavirus vaccine to be delivered to the country.

“The Chinese government informed Germany today that for the time being German citizens in China may be given the BioNTech vaccines,” he said, adding that “around 20,000 Germans would benefit” from the shipment.

He said that Germany was negotiating to win access for “other so-called expatriates” from other countries.

“In return, Chinese citizens in Europe, in Germany, may receive the Chinese vaccine Sinovac, if they so choose,” Hebestreit said.

It was not immediately clear whether other shipments would follow from Berlin.


THE POST'S VIEW

Opinion

China’s new covid nightmare could become a global catastrophe


China’s “zero covid” policy was unsustainable and abruptly scrapped, but the absence of a coherent fallback strategy threatens a fresh set of nightmares for its population, its economy and the Communist Party leadership. A new crisis could shake the whole world. As the Wuhan outbreak demonstrated three years ago, what begins in China does not necessarily stay there.

President Xi Jinping’s government had imposed draconian requirements for lockdowns, tests and forced quarantines during most of the pandemic. But once lifted on Dec. 7, the measures were followed by little guidance from the top. China’s party-state usually declares that everything is under control. Now, it appears to be quite unsettled. A wave of omicron infections is sweeping Beijing and might soon hit the rest of China. It has triggered panic buying of food and cold remedies. A government known for its rigidity and certitude stopped reporting some daily infections data and deactivated the ubiquitous covid-19 tracking app, adding to the uncertainty. Instead of basking in newfound freedom to go out, many people are scared, hunkering down inside.


China has troubled days ahead. Among those 60 years and older, only about 69 percent have received booster shots, and the uptake is even less among those over 80 years old. They are extremely vulnerable to omicron, and reports from China have indicated that a surge of deaths has already started, with crematoriums working around the clock.


Mathematical models predict 1 million or more deaths early next year. China’s government has announced a plan to accelerate vaccination campaigns for the elderly, who have been hesitant to get the shots. For a long while, China has grossly underreported deaths due to covid and probably will continue to do so


One danger is that China’s outbreak will generate new variants that threaten the rest of the world. It is impossible to predict, but previous variants with a transmission edge have spread rather quickly. Millions of infections in China increase the chances of a new variant rising.

Mr. Xi’s motive for ditching the zero-covid policy was to kick-start a lagging economy, burdened by lockdowns and worker unrest. But the new approach might deal a roundhouse blow to the economy. It is causing widespread disruption to production and supply chains. Should China’s manufacturing slow, the world will feel the pain in the form of shortages and inflation.


China unwisely eschewed the effective mRNA vaccines for less-effective Chinese-made shots. The population has not been widely exposed to omicron, and thus lacks natural immunity. A potential lifeline is an aerosol vaccine developed by CanSino Biologics. It is being offered as a booster, in the form of an inhaled mist taken in through the mouth, after studies show it triggered an immune system response in people who had previously received two shots of a Chinese vaccine. The best strategy is pressing this vaccine and importing millions of mRNA shots, too.


Rare public protests that erupted in late November played a role in Mr. Xi’s decision to dump zero covid. Protesters’ wrath could easily return if the situation deteriorates and people lose more faith.


The Post’s View | About the Editorial Board

Editorials represent the views of The Post as an institution, as determined through debate among members of the Editorial Board, based in the Opinions section and separate from the newsroom.


Members of the Editorial Board and areas of focus: Opinion Editor David Shipley; Deputy Opinion Editor Karen Tumulty; Associate Opinion Editor Stephen Stromberg (national politics and policy, legal affairs, energy, the environment, health care); Associate Editor Jonathan Capehart (national politics); Lee Hockstader (immigration; issues affecting Virginia and Maryland); David E. Hoffman (global public health); James Hohmann (domestic policy and electoral politics, including the White House, Congress and governors); Charles Lane (foreign affairs, national security, international economics); Heather Long (economics); Associate Editor Ruth Marcus; and Molly Roberts (technology and society).


No comments: